Stock Events

Stock Events

Aeglea BioTherapeutics (AGLE) Q2 2023 Earnings

11AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-1.66

-1.16

-0.65

-0.15

Details

Expected EPS

-0.15

Actual EPS

-1.66

Surprise EPS

-1.51

Surprise Percent

+1,006.67%

Description

Aeglea BioTherapeutics (AGLE) has reported earnings of -1.66 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.